The prevalence of metabolic syndrome in primary aldosteronism and essential hypertension: A systematic review and meta‐analysis

  • Published on 07/29/2024
  •  Reading time: 4 min.

Kaiwen SunMD, Chenxu ZhouMD, Minghui GongMD, Ying ZhangMD, Yinong JiangMD, Wei SongMD

Department of Cardiology First Affiliated Hospital of Dalian Medical University Dalian Liaoning China

Abstract

It remained debates on metabolic‐related disorders in patients with primary aldosteronism (PA) and essential hypertension (EH). A systematic review and meta‐analysis was conducted to explore the prevalence of metabolic syndrome (MS) and the related indicators in PA and EH. PubMed, Embase, Web of Science and the Cochrane Central Register of Controlled Trials from their commencement to December 2023 were searched for eligible studies. The meta‐analysis was performed...

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Cardiology

Receive our newsletter to stay up to date with the latest news in Cardiology